Neuro-oncology
From the Journals
Detailed glioblastoma map could lead to better treatment approaches
News from the FDA/CDC
New drug approved for relapsed/refractory neuroblastoma
From the Journals
Genomic analysis reveals insights into pathogenesis of neuroblastoma
Researchers identified drivers of disease and potential therapeutic targets.
From the Journals
Early results ‘encouraging’ for CAR NKT cells in neuroblastoma
The CAR NKT cells localized to tumors, and one of three patients treated achieved a response.
Conference Coverage
Evaluating the impact of new pediatric brain tumor classifications
Additional molecular subtypes of childhood brain tumors will have far-reaching implications for diagnosis and management.
From the Journals
Subgroups predict adjuvant chemoradiotherapy benefits in low-grade glioma
From the Journals
Glioma trials should track living well, not just longer
“Patients want to live longer, but they also want to continue to function as well as possible for as long as possible,“ said Terri S. Armstrong,...
From the Journals
QoL good for MGMT-methylated glioblastoma patients with lomustine-temozolide
Adding lomustine to temozolomide did not decrease quality of life for patients, apart from clinically insignificant differences in mental function...
Latest News
Researchers seek a way to predict cognitive deficits in children treated for ALL
Researchers are investigating gene variants and biomarkers that might correlate with chemotherapy-induced cognitive deficits.
From the Journals
Tandem transplants provide EFS edge in pediatric neuroblastoma
Patients randomized to tandem stem cell transplants after successful induction therapy had fewer events than patients assigned to single...
News
Treatment for pediatric low-grade glioma is associated with poor cognitive and socioeconomic outcomes
The risk for poor outcomes is greater when treatment includes radiotherapy, compared with surgery alone.